DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4ae49d/metabolic_syndrome) has announced the addition of Global Markets Direct's new report "Metabolic Syndrome - Pipeline Review, Q4 2010" to their offering.
Metabolic Syndrome Pipeline Review, Q4 2010, provides an overview of the Metabolic Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Metabolic Syndrome , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metabolic Syndrome . Metabolic Syndrome -Pipeline Review 2010, Q4 2010 is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources
Scope
- A snapshot of the global therapeutic scenario for Metabolic Syndrome .
- A review of the Metabolic Syndrome products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Metabolic Syndrome pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
- List of Tables
- List of Figures
- Introduction
- Global Markets Direct Report Coverage
- Metabolic Syndrome Overview
- Therapeutics Development
- An Overview of Pipeline Products for Metabolic Syndrome
- Metabolic Syndrome Therapeutics under Development by Companies
- Metabolic Syndrome Therapeutics under Investigation by Universities/Institutes
- Companies Involved in Metabolic Syndrome Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/4ae49d/metabolic_syndrome